• 1
    Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004; 54: 94-109.
  • 2
    Sondak VK. Sarcomas of bone and soft tissue. In: Greenfield LJ, Mulholland MW, Oldham KT, eds. Surgery: Scientific Principles and Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000: 2258-2280.
  • 3
    Pisters PW, Pollock RE, Lewis VO, et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007; 246: 675-681.
  • 4
    Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996; 14: 1679-1689.
  • 5
    Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791-796.
  • 6
    Edge SB, Byrd DR, Compton CC, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
  • 7
    Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003; 97: 2544-2553.
  • 8
    Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2003; 56: 473-481.
  • 9
    Parsons JT, Zlotecki RA, Reddy KA, Mitchell TP, Marcus RB, Scarborough MT. The role of radiotherapy and limb-conserving surgery in the managment of soft-tissue sarcomas in adults. Hematol Oncol Clin North Am. 2001; 15: 377-388.
  • 10
    Kato I, Severson RK, Schwartz AG. Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology and end results data. Cancer. 2001; 92: 2211-2219.
  • 11
    Christensen LH, Engholm G, Ceberg J, et al. Can the survival difference between breast cancer patients in Denmark and Sweden in 1989 and 1994 be explained by patho-anatomical variables? A population-based study. Eur J Cancer. 2004; 40: 1233-1243.
  • 12
    Meng L, Maskarinec G, Lee J. Ethnicity and conditional breast cancer survival in Hawaii. J Clin Epidemiol. 1997; 50: 1289-1296.
  • 13
    Henson DE, Ries LA, Carriaga MT. Conditional survival of 56,268 patients with breast cancer. Cancer. 1995; 76: 237-242.
  • 14
    Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998; 41: 1097-1106.
  • 15
    Merrill RM, Henson DE, Barnes M. Conditional survival among patients with carcinoma of the lung. Chest. 1999; 116: 697-703.
  • 16
    Fuller CD, Wang SJ, Kachinic L, Wong A, Thomas CR. Conditional survival of gallbladder adenocarcinoma treated with radiotherapy: analysis from the SEER database. Int J Radiat Oncol Biol Phys. 2005; 63: S274.
  • 17
    Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003; 8: 541-552.
  • 18
    National Cancer Institute. Surveillance Epidemiology and End Results Program Web site.1973-2002 public use data. Available at: Accessed August 20, 2009.